Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Dose decrease
Total 0 results
Nothing found
Sponsors and Collaborators
EdiGene Inc.
Giresun University
Park-Klinik Berlin Weißensee
Perosphere Technologies
Jen Ai Hospital
Saitama Medical University International Medical Center
National Institute of Mental Health (NIMH)
Chien Yu Huang
Rizki Darmawan
The Leeds Teaching Hospitals Charitable Foundation
Adriaan Dirk van der Wart
Enas Sayed Farhat
PORTAL CDRN
Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
Amy Fu
Shengyun Lin
Agricultural University of Athens
Hospital for Sick Kids
Our Lady of Lourdes Hospital Waregem
Luxembourg Centre for Systems Biomedicine
View Full List
Medical Conditions
Complication of Transplanted Lung
Premature Retinopathy
Defecatory Functions
Employee Health
Oral Mucosal Anesthesia
Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level
Chronic Conjunctivitis of Both Eyes
Non-small Cell Lung Cancer Stage II
HİP FRACTURE
Arginase 1 Deficiency
Acute Malnutrition
Patient With Cardiovascular-kidney-metabolic Syndrome
Respiratory Distress Syndrome, Infant
Illness Related Work
Esophageal High-Grade Intraepithelial Neoplasia
Congenital Valgus Foot Deformity
Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma
Fasting Mimicking Diet
Macular Degeneration (Age Related)
Intermediate-high Risk
View Full List
Drug Interventions
1/2Ganyan1
AK112 Injection
AKB-6548
Betrixaban
Empagliflozin
NEOK001
Capecitabine
Participants assigned to this arm received injection nalbuphine.
Lurasidone
RiBVD
Two tablets of EHCV in Single Dose each tablet containing SOF 200 mg, RBV 500 mg and Natural anti-hemolytic (AH) at 200 mg
Nitazoxanide 500Mg Oral Tablet
Human protein C concentrate
Heparin
Albuterol HFA (Armstrong's)
Tenofovir Alafenamide 25 MG for arm (A)
CVL-562 (PF-06412562) 4 mg
Clindamycin Gel
Rivaroxaban
Etoricoxib
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Chile
Contract Research Organizations in China
Contract Research Organizations in Djibouti
Contract Research Organizations in Ghana
Contract Research Organizations in India
Contract Research Organizations in Lithuania
Contract Research Organizations in South Africa
Contract Research Organizations in Taiwan
Contract Research Organizations in Tanzania
Contract Research Organizations in Trinidad & Tobago
Contract Research Organizations in Türkiye
Contract Research Organizations in Ukraine
CRO list by country
CROs in Mongolia
SGS
All CROs in Mongolia
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe